title: Multiple eruptive dermatofibromas related to imatinib treatment.
authors: Department of Dermatology, Hospital Universitario de La Princesa, Madrid, Spain.
authors: M
authors: M
authors: Llamas-Velasco
authors: J
authors: J
authors: Fraga
authors: G E
authors: GE
authors: Solano-López
authors: J L
authors: JL
authors: Steegmann
authors: A
authors: A
authors: García Diez
authors: L
authors: L
authors: Requena
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D001706:Biopsy; D005260:Female; D018219:Histiocytoma, Benign Fibrous / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D000068877:Imatinib Mesylate; D007165:Immunosuppression Therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate